Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL-/- Renal Cell Carcinoma Cells-Reference-Cited by-同舟云学术

Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL-/- Renal Cell Carcinoma Cells

Published:2003-11 Issue:45 Volume:278 Page:44966-44974
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Gunaratnam Lakshman,Morley Melissa,Franovic Aleksandra,de Paulsen Natalie,Mekhail Karim,Parolin Doris A.E.,Nakamura Eijiro,Lorimer Ian A.J.,Lee Stephen

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference80 articles.

1. Identification of the von Hippel-Lindau (VHL) Gene

2. Functions of the von Hippel–Lindau tumour suppressor protein

3. von Hippel-Lindau Disease

4. Mutation and Cancer: Statistical Study of Retinoblastoma

5. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HIF-1α in sickle cell disease and cancer: unraveling therapeutic opportunities and risks;Expert Opinion on Therapeutic Targets;2024-05-03

2. “Life has always been physical physical, now visual”: an explorative study on the use of digital health technologies to promote physiotherapy home treatment programs among older people;Physiotherapy Theory and Practice;2024-03-29

3. Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation;Pharmaceuticals;2024-02-01

4. Evolution of the HIF targeted therapy in clear cell renal cell carcinoma;Cancer Treatment Reviews;2023-12

5. ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component;eLife;2023-05-18